148 related articles for article (PubMed ID: 30654309)
21. RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells.
Soong RS; Anchoori RK; Yang B; Yang A; Tseng SH; He L; Tsai YC; Roden RB; Hung CF
Oncotarget; 2016 Oct; 7(42):68489-68502. PubMed ID: 27655678
[TBL] [Abstract][Full Text] [Related]
22. Methionine enkephalin (MENK) inhibits human gastric cancer through regulating tumor associated macrophages (TAMs) and PI3K/AKT/mTOR signaling pathway inside cancer cells.
Wang X; Jiao X; Meng Y; Chen H; Griffin N; Gao X; Shan F
Int Immunopharmacol; 2018 Dec; 65():312-322. PubMed ID: 30343258
[TBL] [Abstract][Full Text] [Related]
23. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
[TBL] [Abstract][Full Text] [Related]
24. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
[TBL] [Abstract][Full Text] [Related]
25. Temporal and spatial profile of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in ischemic stroke in mice.
Kawano T; Shimamura M; Nakagami H; Kanki H; Sasaki T; Mochizuki H
PLoS One; 2019; 14(5):e0215482. PubMed ID: 31048856
[TBL] [Abstract][Full Text] [Related]
26. mTOR inhibitor rapamycin induce polymorphonuclear myeloid-derived suppressor cells mobilization and function in protecting against acute graft-versus-host disease after bone marrow transplantation.
Lin Y; Wang B; Shan W; Tan Y; Feng J; Xu L; Wang L; Han B; Zhang M; Yu J; Yu X; Huang H
Clin Immunol; 2018 Feb; 187():122-131. PubMed ID: 29132870
[TBL] [Abstract][Full Text] [Related]
27. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.
Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A
Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349
[TBL] [Abstract][Full Text] [Related]
28. Methionine enkephalin regulates microglia polarization and function.
Xu X; Gao Y; Wen L; Zhai Z; Zhang S; Shan F; Feng J
Int Immunopharmacol; 2016 Nov; 40():90-97. PubMed ID: 27584058
[TBL] [Abstract][Full Text] [Related]
29. Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment.
Zhou J; Shen Q; Lin H; Hu L; Li G; Zhang X
J Cancer Res Clin Oncol; 2019 Feb; 145(2):329-336. PubMed ID: 30426212
[TBL] [Abstract][Full Text] [Related]
30. CD11b+Gr-1+ myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient mice.
Foks AC; Van Puijvelde GH; Wolbert J; Kröner MJ; Frodermann V; Van Der Heijden T; Van Santbrink PJ; Boon L; Bot I; Kuiper J
Cardiovasc Res; 2016 Aug; 111(3):252-61. PubMed ID: 27234908
[TBL] [Abstract][Full Text] [Related]
31. NFAT-1 hyper-activation by methionine enkephalin (MENK) significantly induces cell apoptosis of rats C6 glioma in vivo and in vitro.
Lu WC; Xie H; Tie XX; Wang R; Wu AH; Shan FP
Int Immunopharmacol; 2018 Mar; 56():1-8. PubMed ID: 29324390
[TBL] [Abstract][Full Text] [Related]
32. Functional modulation of the pathway between dendritic cells (DCs) and CD4+T cells by the neuropeptide: methionine enkephalin (MENK).
Shan F; Xia Y; Wang N; Meng J; Lu C; Meng Y; Plotnikoff NP
Peptides; 2011 May; 32(5):929-37. PubMed ID: 21335041
[TBL] [Abstract][Full Text] [Related]
33. The novel α-glucan YCP improves the survival rates and symptoms in septic mice by regulating myeloid-derived suppressor cells.
Liu D; You M; Zhao GF; Li XJ; Song YX; Dou H; Yao WB; Gao XD; Hou YY
Acta Pharmacol Sin; 2017 Sep; 38(9):1269-1281. PubMed ID: 28649127
[TBL] [Abstract][Full Text] [Related]
34. Macrophage polarization induced by neuropeptide methionine enkephalin (MENK) promotes tumoricidal responses.
Chen W; Liu J; Meng J; Lu C; Li X; Wang E; Shan F
Cancer Immunol Immunother; 2012 Oct; 61(10):1755-68. PubMed ID: 22419372
[TBL] [Abstract][Full Text] [Related]
35. Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma.
Binsfeld M; Muller J; Lamour V; De Veirman K; De Raeve H; Bellahcène A; Van Valckenborgh E; Baron F; Beguin Y; Caers J; Heusschen R
Oncotarget; 2016 Jun; 7(25):37931-37943. PubMed ID: 27177328
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of curcumin on myeloid-derived suppressor cells is requisite for controlling lung cancer.
Liu D; You M; Xu Y; Li F; Zhang D; Li X; Hou Y
Int Immunopharmacol; 2016 Oct; 39():265-272. PubMed ID: 27497194
[TBL] [Abstract][Full Text] [Related]
37. Interaction of Met-enkephalin and corticosteroids in immunomodulation.
Marotti T; Rocić B; Gabrilovac J; Haberstok H
Int J Immunopharmacol; 1992 May; 14(4):621-7. PubMed ID: 1325954
[TBL] [Abstract][Full Text] [Related]
38. The blockage of Notch signalling promoted the generation of polymorphonuclear myeloid-derived suppressor cells with lower immunosuppression.
Wang SH; Lu QY; Guo YH; Song YY; Liu PJ; Wang YC
Eur J Cancer; 2016 Nov; 68():90-105. PubMed ID: 27728841
[TBL] [Abstract][Full Text] [Related]
39. Daunorubicin conjugated with alpha-fetoprotein selectively eliminates myeloid-derived suppressor cells (MDSCs) and inhibits experimental tumor growth.
Belyaev NN; Abdolla N; Perfilyeva YV; Ostapchuk YO; Krasnoshtanov VK; Kali A; Tleulieva R
Cancer Immunol Immunother; 2018 Jan; 67(1):101-111. PubMed ID: 28956104
[TBL] [Abstract][Full Text] [Related]
40. Juglone eliminates MDSCs accumulation and enhances antitumor immunity.
Wang H; Zou C; Zhao W; Yu Y; Cui Y; Zhang H; E F; Qiu Z; Zou C; Gao X
Int Immunopharmacol; 2019 Aug; 73():118-127. PubMed ID: 31085459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
